ASGCT Policy Summit, Day 3
Washington, DC - Nov. 6, 2019 The American Society of Gene and Cell Therapy held a 3 day summit to discuss policy and other issues around gene editing and gene therapy. Day 1 addressed regulatory issues in gene therapy development Day 2 dealt with payment policies around gene therapy Day 3 (the day I attended) was focused on the ethical, societal, and policy issues around germline gene editing Links to some of the presentations can be found on ASGCT’s website....